Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5642 Journals

4484 Congresses

10100+ Unique Records

Therapeutic Advances in Infectious Disease

Title Abbreviation

Ther Adv Infect Dis

ISSN

2049-9361

Electronic ISSN

2049-937X

Therapeutic Area

Clinical Pharmacology, Health Economics/Outcomes Research, Hospital Medicine, Infectious Diseases/ Infectology, Pharmacoeconomics, Pharmacology

Readership

Clinical Pharmacologists, Clinicians, Hospitalists, Infectious Disease Specialists, Pharmaco-Epidemiologists, Pharmacologists, Physician Assistants, Physicians, Physicians - Medicine, Researchers, Residents, Scientists

Scope

Therapeutic Advances in Infectious Disease delivers the highest quality peer-reviewed open access original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of infectious diseases. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in infectious disease and related disciplines (including infection control), providing an online forum for rapid dissemination of recent research and perspectives in this area. Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). Therapeutic Advances in infectious Disease conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract. The journal adheres to a blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees; and Online First publication is usually within 3 weeks of Acceptance.

Sponsoring Association(s)

No associations affiliated with this journal

Publisher Name

SAGE Publications - UK

To see more details about Therapeutic Advances in Infectious Disease, Subscribe Now!

Submission to Acceptance Acceptance to Online Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
	– Kait G Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
	– Michael K. Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
	- Weill Cornell Medical Library

Journals ● Congresses ● Associations

Privacy Policy ● Terms of Service ● Glossary ● OSS ● Contact Us